China Ramps up Production of Generic Medicine
JUNE 6, 2018
Last year, China boasted the world’s second largest pharmaceutical market. How could a new flood of cheap, mass-produced generics from China affect the US pharma sector given current trade tensions? China and the Generics Market. While the country has been known to rely largely on generics already (over 95% of China’s FDA approvals have been granted to generic medicines), the industry has also been plagued by concerns about the quality and effectiveness of non-branded drugs.